Business Combinations Business Combinations Pro forma (Details) (Caliper Life Sciences [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 9 Months Ended |
---|---|---|
Oct. 02, 2011
|
Oct. 02, 2011
|
|
Caliper Life Sciences [Member]
|
||
Business Acquisition [Line Items] | ||
Business Acquisition, Pro Forma Revenue | $ 489,623 | $ 1,489,384 |
Business Acquisition, Pro Forma Net Income (Loss) | $ 18,430 | $ 51,973 |
Business Acquisition, Pro Forma Earnings Per Share, Basic | $ 0.16 | $ 0.46 |
Business Acquisition, Pro Forma Earnings Per Share, Diluted | $ 0.16 | $ 0.46 |
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|